Changes Nov. 23, 2021
The following is a list of changes on monitored regulatory lists which occurred between Nov. 16, 2021 and Nov. 23, 2021.
Legend
- regulatory records added to the list
- regulatory records removed from the list
- changed regulatory records
For changed records, you can see the history of changes by following the link to the corresponding regulatory record.
Biocidal active substances
- 1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl) urea (Hexaflumuron)
- 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole)
- 2,2-dibromo-2-cyanoacetamide (DBNPA)
- 2-hydroxy-.alpha.,.alpha.,4-trimethylcyclohexanemethanol
- 3-iodo-2-propynylbutylcarbamate (IPBC)
- Aluminium phosphide releasing phosphine
- Aluminium phosphide releasing phosphine
- Amines, C10-16-alkyldimethyl, N-oxides
- Boric acid
- Bronopol
- Capsicum annuum, ext.
- Chlorine dioxide generated from sodium chlorite and sodium persulfate
- Chlorine dioxide generated from sodium chlorite and sodium persulfate
- Chlorine dioxide generated from sodium chlorite and sodium persulfate
- Chlorine dioxide generated from sodium chlorite and sodium persulfate
- Chlorine dioxide generated from sodium chlorite and sodium persulfate
- Creosote
- Dinotefuran
- Disodium tetraborate pentahydrate
- Eucalyptus citriodora oil and citronellal, hydrated, cyclized
- Indoxacarb (enantiomeric reaction mass S:R 75:25)
- Magnesium phosphide releasing phosphine
- Malt, ext.
- Metam-sodium
- Metam-sodium
- Peroxyoctanoic acid
- Peroxyoctanoic acid
- Peroxyoctanoic acid
- Reaction mass of (6E)-N-(4-hydroxy-3-methoxy-2-methylphenyl)-8-methylnon-6-enamide and N-(4-hydroxy-3-methoxy-2-methylphenyl)-8-methylnonanamide
- Silver, as a nanomaterial
- Silver, as a nanomaterial
- Silver, as a nanomaterial
- Tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione (Dazomet)
- Thiram
- tebuconazole
Registered substances
- (1R,2S)-2-ethenyl-1-(ethoxycarbonyl)cyclopropanaminium (2S)-2-[(4-chlorobenzoyl)oxy]propanoate
- (2E)-3-(4-isobutylphenyl)-2-methylacrylaldehyde
- 1,3-bis(2,4,4-trimethylpentan-2-yl)trisulfane
- 1H-Indole-3-carboxylic acid, 6-cyano-2-[1-(4-ethyl-3-iodophenyl)-1-methylethyl]-, 1,1-dimethylethyl ester
- 4''-Butoxy-4-ethyl-2',2'',3''-trifluoro-[1,1':4',1'']-terphenyl
- Amides, C16-18 (even numbered) saturated and C18 unsaturated, N,N'-[[(2-hydroxyethyl)imino]di-2,1-ethanediyl]bis-, ethoxylated (1-2.5 mol)
- Avermectin A1a, 25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)-
- C.I. Reactive Orange 116
- Estr-5(10)-en-17-one, 3,3-dimethoxy-
- Phenol, 2-[3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-, hydrochloride (1:1)
- Salts of amine-neutralised aliphatic carboxylic acids
- cis-N-hydroxy-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin- 4-yl)amino]cyclobutanecarboxamide
- reaction mass of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-2H -isothiazol-3-one
Registry of CLH intentions until outcome
- 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol
- fenpropidin (ISO); (R,S)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine
- halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-pyrazole-4-carboxylate